Clinical Trial Update: ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aspirin in patients with immune thrombocytopenia and cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Immune Thrombocytopenia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Purpura, Thrombocytopenic | Phase 2 | Status: COMPLETED